Sunmi Ju

Sunmi Ju

Auto-generated profile, based on publicly available information

Sunmi Ju

Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Republic of Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2017 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
SJSunmi Ju
Sunmi Ju
SLSeung Jun Lee
Seung Jun Lee
MPMi Jung Park
Mi Jung Park
YCYu Ji Cho
Yu Ji Cho
YJYi Yeong Jeong
Yi Yeong Jeong
HKHo Cheol Kim
Ho Cheol Kim

1 January 2018 in Tuberculosis and Respiratory Diseases
Verified
Journal Article
Open access
PDF file
SJSunmi Ju
Sunmi Ju
TLTae Won Lee
Tae Won Lee
JYJung-Wan Yoo
Jung-Wan Yoo
SLSeung Jun Lee
Seung Jun Lee
YCYu Ji Cho
Yu Ji Cho
HKHO CHEOL KIM
HO CHEOL KIM
Ju S, et al. Tuberc Respir Dis. 2018 Oct;81(4):311-318. https://doi.org/10.4046/trd.2017.0081

1 January 2021 in Chronic Respiratory Disease
Verified
Journal Article
Open access
PDF file
SJSunmi Ju
Sunmi Ju
JJJong Hwan Jeong
Jong Hwan Jeong
MHManbong Heo
Manbong Heo
IHI RE Heo
I RE Heo
TKTae Hoon Kim
Tae Hoon Kim
SLSeung Jun Lee
Seung Jun Lee
We evaluated serum albumin as an index for predicting respiratory hospitalization in patients with bronchiectasis. We retrospectively reviewed the medical records of 177 patients with bronchiectasis, categorized them into low and normal albumin groups, and compared their clinical characteristics. The prediction of respiratory hospitalization by factors such as serum albumin level, bronchiectasis severity index (BSI), and FACED score (an acronym derived from five variables of forced expiratory volume in 1 s; FEV1, age, chronic colonization of Pseudomonas aeruginosa, extent of bronchiectasis, and dyspnea) was assessed. There were 15 and 162 patients categorized in the low and normal albumin groups, respectively. The low albumin group had lower body mass index and forced expiratory volume in 1 s, and higher age, frequency of previous respiratory hospitalization, percentage of Pseudomonas colonization, number of affected lobes, BSI and FACED scores, and C-reactive protein (CRP) level, than the normal albumin group. The areas under the receiver operating characteristic curve of serum albumin level and BSI and FACED scores for predicting respiratory hospitalization were 0.732 (95% confidence interval (CI), 0.647–0.816), 0.873 (95% CI, 0.817–0.928), and 0.708 (95% CI, 0.618–0.799), respectively. Albumin level, CRP, modified Medical Research Council score, and chronic Pseudomonas aeruginosa (and other organisms) colonization were independent risk factors for respiratory hospitalization. Low serum albumin level was associated with worse clinical condition, higher severity scores, and respiratory hospitalization in patients with bronchiectasis.

1 August 2021 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
IHI RE Heo
I RE Heo
HKHO CHEOL KIM
HO CHEOL KIM
SLSeung Jun Lee
Seung Jun Lee
JYJung-Wan Yoo
Jung-Wan Yoo
SJSunmi Ju
Sunmi Ju
TKTae Hoon Kim
Tae Hoon Kim
Background: Preserved ratio impaired spirometry (PRISm) is a common spirometric pattern that is associated with respiratory symptoms and higher mortality rates. However, the relationship between lung cancer and PRISm remains unclear. This study investigated the clinical characteristics of lung cancer patients with PRISm and the potential role of PRISm as a prognostic factor.Methods: We retrospectively reviewed data collected from 2014 to 2015 in the Korean Association for Lung Cancer Registry. We classified all patients into three subgroups according to lung function as follows: normal lung function; PRISm (forced expiratory volume in 1 s [FEV1] < 80% predicted and FEV1/forced vital capacity [FVC] ≥ 0.7); and chronic obstructive pulmonary disease (COPD; FEV1/FVC < 0.7). In non–small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), the overall survival period was compared among the three subgroups. The prognostic factors were investigated using Cox regression analysis.Results: Of the 3763 patients, 38.6%, 40.1%, and 21.3% had normal lung function, COPD, and PRISm, respectively. Patients with PRISm had poorer overall survival than those with COPD or normal lung function in NSCLC and SCLC (Mantel–Cox log‐rank test, p < 0.05). In the risk‐adjusted analysis, overall survival was independently associated with COPD (hazard ratio [HR] 1.209, p = 0.027) and PRISm (HR 1.628, p < 0.001) in NSCLC, but was only associated with PRISm (HR 1.629, p = 0.004) in SCLC.Conclusions: PRISm is a significant pattern of lung function in patients with lung cancer. At the time of lung cancer diagnosis, pre‐existing PRISm should be considered a predictive factor of poor prognosis.

1 April 2019 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
SLSeung Jun Lee
Seung Jun Lee
SYSang Suk Yun
Sang Suk Yun
SJSunmi Ju
Sunmi Ju
JYJung-Wan Yoo
Jung-Wan Yoo
YCYu Ji Cho
Yu Ji Cho
JLJong Deog Lee
Jong Deog Lee
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released an updated document in 2017 that excluded the spirometric parameter in the classification of patients. The validity of this new classification system in predicting mortality and respiratory hospitalization is still uncertain. Methods: Outpatients (n=149) with chronic obstructive pulmonary disease (COPD) who underwent spirometry and six-minutes walking test from October 2011 to September 2013 were enrolled. The overall mortality and rate of respiratory hospitalization over a median of 61 months were analyzed. Kaplan-Meier survival analyses, receiver operaing curve analyses with areas under the curve (AUCs), and logistic regression analyses for GOLD 2007, GOLD 2011, GOLD 2017, and/or BODE index were performed to evaluate their abilities to predict mortality and respiratory hospitalization. Results: Forty-two (53.2%) patients in 2011 GOLD C or D group were categorized into 2017 GOLD A or B group. The odds ratios of GOLD 2017 group C and group D relative to group A were 7.55 (95% CI, 1.25–45.8) and 25.0 (95% CI, 6.01–102.9) for respiratory hospitalization. Patients in GOLD 2017 group A and group B had significantly better survival (log-rank test, p<0.001) compared with patients in group D; however, survival among patients in GOLD 2007 groups and GOLD 2011 groups was comparable. The AUC values for GOLD 2007, GOLD 2011, GOLD 2017, and BODE index were 0.573, 0.624, 0.691, 0.692 for mortality (p=0.013) and 0.697, 0.707, 0.741, and 0.754 for respiratory hospitalization (p=0.296), respectively. Conclusion: The new GOLD classification may perform better than the previous classifications in terms of predicting mortality and respiratory hospitalization.

1 January 2023 in Infection & Chemotherapy
Verified
Journal Article
Open access
KHKyung-Wook Hong
Kyung-Wook Hong
JYJung Wook Yang
Jung Wook Yang
JKJong Duk Kim
Jong Duk Kim
SJSunmi Ju
Sunmi Ju
MCMin-Chul Cho
Min-Chul Cho
IBIn-Gyu Bae
In-Gyu Bae
Hong KW, et al. Infect Chemother. 2023 Jan;55:e2. https://doi.org/10.3947/ic.2022.0128